找到约 13 条 “AC 253” 相关结果 （用时 0.12 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
| M7619 | AC-93253 iodide | AC-93253 iodide | Others |
| AC-93253是一种有效的、细胞通透性、亚型选择性RAR (RARα)激动剂。 | |||
| M11920 | ChemBridge-5253508 | ChemBridge化合物-5253508 | Screening Compounds and Building Blocks |
| N-(5-{2-[(4-bromophenyl)sulfonyl]ethyl}-1,3,4-thiadiazol-2-yl)acetamide (5253508) | |||
| ChemBridge特有类药化合物/先导化合物-5253508，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13033 | ChemBridge-7881253 | ChemBridge化合物-7881253 | Screening Compounds and Building Blocks |
| N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-5-nitro-2-furamide (7881253) | |||
| ChemBridge特有类药化合物/先导化合物-7881253，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13288 | ChemBridge-50882536 | ChemBridge化合物-50882536 | Screening Compounds and Building Blocks |
| ethyl 1-[4-(acetylamino)benzyl]-4-(2-phenylethyl)-4-piperidinecarboxylate (50882536) | |||
| ChemBridge特有类药化合物/先导化合物-50882536，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
M30769
|
AC-262536 | AC-262536 | Androgen Receptor |
| AC-262536 是一种选择性的非甾体雄激素受体调节剂 (SARM)，具有有益的合成代谢作用。AC-262536 对雄激素受体具有强效激动剂活性，亲和力在低纳摩尔范围 (1-10 nM)。 | |||
| M45523 | ChemBridge-5253145 | ChemBridge化合物-5253145 | Screening Compounds and Building Blocks |
| 4-{[4-chloro-3-(1-piperidinylsulfonyl)benzoyl]amino}benzoic acid (5253145) | |||
| ChemBridge特有类药化合物/先导化合物-5253145，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48589 | ChemBridge-63625302 | ChemBridge化合物-63625302 | Screening Compounds and Building Blocks |
| 2-[1-(2-fluorobenzyl)-2-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-3-yl]-N-3-pyrrolidinylacetamide hydrochloride (63625302) | |||
| ChemBridge特有类药化合物/先导化合物-63625302，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48651 | ChemBridge-66253794 | ChemBridge化合物-66253794 | Screening Compounds and Building Blocks |
| 2-(aminomethyl)-N-{4-[(1-piperidinylacetyl)amino]phenyl}-1,3-oxazole-4-carboxamide dihydrochloride (66253794) | |||
| ChemBridge特有类药化合物/先导化合物-66253794，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48914 | ChemBridge-79253850 | ChemBridge化合物-79253850 | Screening Compounds and Building Blocks |
| 2-(4,6-dimethyl-1-benzofuran-3-yl)-N-{2-[2-(hydroxymethyl)piperidin-1-yl]ethyl}acetamide (79253850) | |||
| ChemBridge特有类药化合物/先导化合物-79253850，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M50133 | ChemBridge-8802535 | ChemBridge化合物-8802535 | Screening Compounds and Building Blocks |
| 3-({2-[(4-tert-butylphenoxy)acetyl]hydrazino}carbonyl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid (8802535) | |||
| ChemBridge特有类药化合物/先导化合物-8802535，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M52429 | AC 253 | AC 253 | Amyloid |
| AC 253 是 amylin 的拮抗剂，抑制 125I-adrenomedullin 结合，其IC50 值为 25 nM。 | |||
| M13539
|
APTO-253 | APTO-253 | c-Myc |
| LOR-253; LT-253 | |||
| APTO-253 (LOR-253) 是一种小分子，可抑制c-Myc表达，稳定 G-四链体 DNA 并诱导急性髓样白血病细胞的细胞周期停滞和凋亡。APTO-253 通过诱导 Kruppel-like factor 4 (KLF4) 抑癌因子介导抗癌活性。APTO-253 具有抗关节炎活性。 | |||
| M20833 | Vodobatinib (K0706) | Vodobatinib (K0706) | Src-bcr-Abl |
| SCO-088, SUN K706, SUN-K0706 | |||
| Vodobatinib (K0706, SCO-088, SUN K706, SUN-K0706) is a novel BCR-ABL1 tyrosine kinase inhibitor with an IC50 of 7 nM. Vodobatinib exhibits activity against most BCR-ABL1 point mutants with IC50s of 167 nM, 154 nM,165 nM and 1967 nM for BCR-ABL1L248R, BCR-ABL1Y253H , BCR-ABL1E255V and BCR-ABL1T315I, respectively. | |||
